Equity (Tables)

6 Months Ended

Mar. 31, 2015

Equity [Abstract]

Schedule of Stock Options Activity

The following table summarizes stock option activity under the Equity Plans for the six months ended March 31, 2015:

	Number of Shares		Weighted Average Exercise Price	Weighted Average Remaining Contractual Life (in years)	Aggregate Intrinsic Value (*) (in thousands)
Outstanding as of September 30, 2014	1,431,190		$19.06
Granted	9,650		$5.34
Exercised	(123,387	)	$4.54		$	95
Forfeited	(8,027	)	$5.12
Expired	(79,503	)	$17.27
Outstanding as of March 31, 2015	1,229,923		$20.62	2.08	$	265
Exercisable as of March 31, 2015	1,210,320		$20.86	1.97	$	258
Vested and expected to vest as of March 31, 2015	1,226,293		$20.66	2.06	$	264

(*) Intrinsic value for stock options represents the “in-the-money” portion or the positive variance between a stock option's exercise price and the underlying stock price. For the six months ended March 31, 2014, the intrinsic value of options exercised was $4,000.

Schedule of Valuation Assumptions

The fair value of each stock option grant was estimated on the date of grant using the Black-Scholes option valuation model, adhering to the straight-line attribution approach using the following weighted-average assumptions, of which the expected term and stock price volatility rate are highly subjective:

	For the Three Months Ended March 31,					For the Six Months Ended March 31,
	2015		2014			2015			2014
Black-Scholes weighted average assumptions:
Expected dividend rate	—	%	—		%	—		%	—		%
Expected stock price volatility rate	72.7	%	93.4		%	76.0		%	93.8		%
Risk-free interest rate	1.7	%	1.9		%	1.8		%	1.9		%
Expected term (in years)	6.0		6.0			6.0			6.0
Weighted average grant date fair value per share of stock options granted:	$3.51		$	3.76		$	3.55		$	3.79

Schedule of Restricted Stock Activity

The following table summarizes the activity related to RSUs for the six months ended March 31, 2015:

Restricted Stock Activity	Restricted Stock Units
	Number of Shares		Weighted Average Grant Date Fair Value
Non-vested as of September 30, 2014	966,579		$4.71
Granted	507,400		$5.36
Vested	(838,827	)	$4.75
Forfeited	(41,949	)	$4.86
Non-vested as of March 31, 2015	593,203		$5.20

Schedule of Stock-based Compensation Expense - By Award Type

The effect of recording stock-based compensation expense was as follows:

Stock-based Compensation Expense - by award type	For the three months ended March 31,				For the six months ended March 31,
(in thousands)	2015		2014		2015		2014
Employee stock options	$	7	$	29	$	184	$	78
Restricted stock awards and units	797		424		2,056		918
Employee stock purchase plan	14		75		64		163
401(k) match in common stock	144		125		224		203
Outside director fees in common stock	72		85		280		195
Total stock-based compensation expense	$	1,034	$	738	$	2,808	$	1,557

Schedule Stock-based Compensation Expense - By Expense Type

Stock-based Compensation Expense - by expense type	For the three months ended March 31,				For the six months ended March 31,
(in thousands)	2015		2014		2015		2014
Cost of revenue	$	81	$	117	$	185	$	226
Selling, general, and administrative	849		457		2,414		1,010
Research and development	104		164		209		321
Total stock-based compensation expense	$	1,034	$	738	$	2,808	$	1,557

Schedule of Earnings Per Share, Basic and Diluted

The following table sets forth the computation of basic and diluted net income (loss) per share:

Basic and Diluted Net (Loss) Income Per Share	For the Three Months Ended March 31,						For the Six Months Ended March 31,
(in thousands, except per share)	2015			2014			2015			2014
Numerator
Loss from continuing operations	$	(956	)	$	(4,722	)	$	(4,086	)	$	(8,545	)
Income (loss) from discontinued operations	4,008			(710		)	63,266			1,059
Total	3,052			(5,432		)	59,180			(7,486		)
Undistributed earnings allocated to common shareholders for basic net income (loss) per share	$	3,052		$	(5,432	)	$	59,180		$	(7,486	)
Undistributed earnings allocated to common shareholders for diluted net income (loss) per share	$	3,052		$	(5,432	)	$	59,180		$	(7,486	)
Denominator:
Denominator for basic net income (loss) per share - weighted average shares outstanding	32,077			30,392			31,640			30,162
Dilutive options outstanding, unvested stock units and ESPP	—			—			—			—
Denominator for diluted net income (loss) per share - adjusted weighted average shares outstanding	32,077			30,392			31,640			30,162
Net income (loss) per basic and diluted shares:
Continuing operations	$	(0.03	)	$	(0.16	)	$	(0.13	)	$	(0.28	)
Discontinued operations	0.13			(0.02		)	2.00			0.03
Net income (loss) per basic share	$	0.10		$	(0.18	)	$	1.87		$	(0.25	)
Weighted average antidilutive options, unvested restricted stock units and awards, warrants and ESPP shares excluded from the computation	2,214			3,028			2,434			2,653
Average market price of common stock	$	5.34		$	4.96		$	5.32		$	5.00

Schedule of Common Stock Reserved for Future Issuances

As of March 31, 2015, we had common stock reserved for the following future issuances:

Future Issuances	Number of Common Stock Shares Available for Future Issuances
Exercise of outstanding stock options	1,229,923
Unvested restricted stock units	593,203
Purchases under the employee stock purchase plan	1,020,874
Issuance of stock-based awards under the Equity Plans	612,707
Exercise of outstanding warrants	400,001
Purchases under the officer and director share purchase plan	88,741
Total reserved	3,945,449